The invention relates to recombinantly or synthetically produced HCV E1
envelope proteins or parts thereof comprising disulfides between specific
cysteine residues. The invention further relates to viral-like particles
and compositions comprising said HCV E1 envelope proteins or parts
thereof as well as to methods using said HCV E1 envelope proteins or
parts thereof, and to kits comprising said HCV E1 envelope proteins or
parts thereof.